# Hepatitis B Vaccine

## Engerix-B inj 1mL/dose (Private)

##### 

| TAH Drug Code      | IHBV                                                                                                                                                                                                                                                                                                                                                                                |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Active immunisation against hepatitis B virus infection                                                                                                                                                                                                                                                                                                                             |
| Dosing             | IM, > or = 20 years 20 mcg/1mL/dose, < or = 19 years 10 mcg/0.5 mL/dose, 3 doses at 0, 1, and 6 months or 4 doses at 0, 1, 2, and 12 months. > or = 20 years rapid immunization 3 doses at 0, 7, and 21 days with a booster at 12 months. Renal insufficiency > or = 16 years 4 double doses (20 mcg x 2) at 0, 1, 2, and 6 months. 11-15 years 2 doses (20 mcg) at 0 and 6 months. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | Hypersensitivity.                                                                                                                                                                                                                                                                                                                                                                   |
| Adverse Effects    | Redness, pain, swelling at inj site. Rarely, fatigue, fever, malaise, influenza-like symptoms, dizziness, headache, paresthesia, nausea, vomiting, diarrhea, abdominal pain, abnormal liver function tests, arthralgia, myalgia, rash, pruritus, urticaria.                                                                                                                         |
| Pregnancy          | Compatible                                                                                                                                                                                                                                                                                                                                                                          |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                       |

## Hepatitis B vaccine (Government) 0.5mL/dose

##### 

| TAH Drug Code      | IHBV1                                                                                                                                                                                                                                                                                                                                                                               |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Active immunisation against hepatitis B virus infection                                                                                                                                                                                                                                                                                                                             |
| Dosing             | IM, > or = 20 years 20 mcg/1mL/dose, < or = 19 years 10 mcg/0.5 mL/dose, 3 doses at 0, 1, and 6 months or 4 doses at 0, 1, 2, and 12 months. > or = 20 years rapid immunization 3 doses at 0, 7, and 21 days with a booster at 12 months. Renal insufficiency > or = 16 years 4 double doses (20 mcg x 2) at 0, 1, 2, and 6 months. 11-15 years 2 doses (20 mcg) at 0 and 6 months. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | Hypersensitivity.                                                                                                                                                                                                                                                                                                                                                                   |
| Adverse Effects    | Redness, pain, swelling at inj site. Rarely, fatigue, fever, malaise, influenza-like symptoms, dizziness, headache, paresthesia, nausea, vomiting, diarrhea, abdominal pain, abnormal liver function tests, arthralgia, myalgia, rash, pruritus, urticaria.                                                                                                                         |
| Pregnancy          | Compatible                                                                                                                                                                                                                                                                                                                                                                          |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                       |

